3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
Cytarabine
7
Daunorubicin
5
Azacitidine
5
venetoclax
3
Decitabine
3
ivosidenib
2
decitabine and cedazuridine drug combination
2
cedazuridine
2
Mitoxantrone
2
Idarubicin
2
Etoposide
2
treosulfan
1
tagraxofusp
1
revumenib
1
quizartinib
1
olutasidenib
1
glasdegib
1
gilteritinib
1
fludarabine
1
etoposide phosphate
1
enasidenib
1
cc-486
1
Midazolam
1
Itraconazole
1
Granulocyte Colony-Stimulating Factor
1
Gemtuzumab
1
Drug Therapy
1
Cobicistat
1
CPX-351
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Leukemia, Myeloid, Acute
×
palbociclib
×
Clear all
No trials found.